In last trading session, Blueprint Medicines Corp (NASDAQ:BPMC) saw 2.44 million shares changing hands with its beta currently measuring 0.87. Company’s recent per share price level of $128.25 trading at -$0.01 or -0.01% at ring of the bell on the day assigns it a market valuation of $8.29B. That closing price of BPMC’s stock is at a discount of -0.16% from its 52-week high price of $128.45 and is indicating a premium of 43.05% from its 52-week low price of $73.04.
For Blueprint Medicines Corp (BPMC), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.90. Splitting up the data highlights that, out of 10 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 4 suggested the stock as a Hold whereas 6 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Blueprint Medicines Corp (NASDAQ:BPMC) trade information
Upright in the red during last session for losing -0.01%, in the last five days BPMC remained trading in the green while hitting it’s week-highest on Monday, 06/23/25 when the stock touched $128.25 price level, adding 0.16% to its value on the day. Blueprint Medicines Corp’s shares saw a change of 23.05% in year-to-date performance and have moved 0.02% in past 5-day. Blueprint Medicines Corp (NASDAQ:BPMC) showed a performance of 26.35% in past 30-days.
Wall Street analysts have assigned a consensus price target of 141 to the stock, which implies a rise of 9.04% to its current value. Analysts have been projecting 132 as a low price target for the stock while placing it at a high target of 150. It follows that stock’s current price would drop -2.92% in reaching the projected high whereas dropping to the targeted low would mean a loss of -2.92% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 31.87% during past 5 years.
Blueprint Medicines Corp (NASDAQ:BPMC)’s Major holders
BLACKROCK INC. is the top institutional holder at BPMC for having 6.65 million shares of worth $716.45 million. And as of 2024-06-30, it was holding 10.5758 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 6.54 million shares on 2024-06-30. The number of shares represents firm’s hold over 10.4026 of outstanding shares, having a total worth of $704.72 million.
